• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL THROMBECTOMY; EMBOLECTOMY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL THROMBECTOMY; EMBOLECTOMY CATHETER Back to Search Results
Catalog Number UNKREVIVESE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage, Cerebral (1889)
Event Date 12/31/2015
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because no lot number was provided by the customer.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Cerenovus manufacturer's report numbers: 2954740-2020-00001, 2954740-2020-00002, 2954740-2020-00003, 2954740-2020-00005 are related to the same incident.
 
Event Description
This complaint is from a literature source.As reported in the literature publication entitled, ¿effect of balloon guide catheter utilization on contact aspiration thrombectomy¿ (pmid: 30497154).10 patients with acute ischemic stroke due to relevant intracranial internal carotid artery (ica) or middle cerebral artery (mca) m1 or proximal m2 segment occlusion who underwent contact aspiration thrombectomy (cat) experienced parenchymal hematoma type 1.Objective the role of the balloon guide catheter (bgc) has not been evaluated in contact aspiration thrombectomy (cat) for acute stroke.Here, the authors aimed to test whether the bgc was associated with recanalization success and good functional outcome in cat.Methods all patients who had undergone cat as the first line treatment for anterior circulation intracranial large vessel occlusion were retrospectively identified from prospectively maintained registries for six stroke centers.The patients were dichotomized into bgc utilization and nonutilization groups.Clinical findings, procedural details, and recanalization success rates were compared between the two groups.Whether the bgc was associated with recanalization success and functional outcome was assessed.Patient data were obtained from the prospectively maintained registries for six comprehensive stroke centers for the period between january 2011 and december 2015 cerenovus devices (revive distal access catheter) were used in this study.No devices specific information (including amount, catalog and lot number) were provided in the article.Concomitant products: penumbra reperfusion catheter, penumbra inc.; navien distal access catheter, medtronic neurovascular; shuttle, cook medical; neuronmax, penumbra inc; merci, stryker neurovascular; optimo, tokai medical; cello, medtronic neurovascular) cerenovus takes a conservative approach to report those events under cerenovus devices.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THROMBECTOMY
Type of Device
EMBOLECTOMY CATHETER
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
821 fox lane
san jose CA 95131
Manufacturer (Section G)
MICRUS ENDOVASCULAR
821 fox lane
san jose CA 95131
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key9566635
MDR Text Key188901117
Report Number2954740-2020-00004
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKREVIVESE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/19/2019
Initial Date FDA Received01/08/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age68 YR
-
-